+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alder BioPharmaceuticals Inc - logo

Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic antibodies. Its lead product candidate is Eptinezumab, a monoclonal antibody that inhibits calcitonin gene-related peptide (CGRP). Its being developed as a migraine prevention treatment for patients with chronic and frequent episodic migraine. The company is also evaluating ALD1910, which is designed to specifically inhibit pituitary adenylate cyclase-activating peptide-38. Alder was founded in 2002 and is headquartered in Bothell, Washington.

From
From
From
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • October 2016
  • 59 Pages
From
From
From
Global Migraine Therapeutics Market 2018-2022 - Product Thumbnail Image

Global Migraine Therapeutics Market 2018-2022

  • Report
  • June 2018
  • 102 Pages
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • May 2019
  • 480 Pages
From
From
From
From
From
From
Loading Indicator
adroll